GLP-1 plays a crucial role in regulating several physiological and metabolic functions, including appetite, satiety, glucose and insulin balance, GI motility, liver fat metabolism, and even bone remodeling (1)
Based on the reluctance of major Part D plan sponsors to participate in the BALANCE Model in 2027 under the original specifications, it appears that sponsors had insufficient data to estimate their added costs associated with covering GLP-1s for obesity
In contrast, Mounjaro is both a GLP-1 receptor and GIP receptor agonist
GLP-1 analogues, such as semaglutide (brand names Ozempic, Wegovy) that were initially licensed for treating type 2 diabetes have received a lot of publicity in the past couple of years, in great part due to their ability to help people lose weight
Diabetes medications and body weight
No certificate of analysis